
Prostate-Specific Antigen (PSA) Test - NCI
Jan 31, 2025 · Learn what a PSA test is, plus the limitations and potential harms of the test when used to screen for prostate cancer.
The Benchmarking Tool - SEER
Background The National Cancer Institute Surveillance Research Program (NCI-SRP) has developed a new quality control tool allowing Surveillance, Epidemiology, and End Results …
Prueba del antígeno prostático específico (PSA)
Entérese de qué es una prueba del PSA, y de las limitaciones y los posibles daños de la prueba cuando se usa para detectar el cáncer de próstata.
PSA (Prostatic Specific Antigen) Lab Value (2018+) SSDI (NAACCR #3920) in Schema ID 00580 PSA: protein produced by the cells of prostate gland; used in staging and treatment monitoring …
Lesson 5: Downloading data from the SRA
SRA Biowulf Unix Lesson 5: Downloading data from the SRA Lesson 4 Review: The majority of computational tasks on Biowulf should be submitted as jobs: sbatch or swarm the SRA-toolkit …
State Cancer Profiles > Screening and Risk Factors Table
New: County level modeled estimates for breast or cervical screening, smoking, and colorectal screening. How do you find them?
PSA (Prostatic Specific Antigen) Lab Value | EOD Data SEER*RSA
PSA (Prostatic Specific Antigen) is a protein produced by cells of the prostate gland and is elevated in patients with prostate cancer. This data item pertains to PSA lab value.
An Open-label Study Comparing Lutetium (177Lu) Vipivotide …
Serum/plasma PSA progression is defined as 2 increases in PSA measured at least 1 week apart. The minimal start value is 2.0 ng/mL; 1.0 ng/mL is the minimal starting value if confirmed rise …
Impacts of prevention, screening, treatment on cancer deaths
Dec 5, 2024 · In prostate cancer, of the 360,000 deaths averted (out of 1.01 million), screening via PSA testing contributed 56% and treatment advances contributed 44%. “These findings …
An Improved Prostate Cancer Biomarker Test May Help Men Avoid ...
Apr 29, 2024 · Researchers funded by NCI have developed and validated a new prostate cancer urinary biomarker test that can help differentiate who should proceed for biopsy after an …